ENTITY

SciSparc (SPRC US)

83
Analysis
Health Care • Israel
SciSparc Ltd. provides pharmaceutical products. The Company develops cannabinoid technologies for treatment of central nervous system disorders. SciSparc serves customers worldwide.
more
bullish•Dohome
•04 Aug 2026 15:52•Broker

KTX TACTICAL PICKS - August 4, 2026 (Eng.)

We remove PTT and SPRC from the portfolio after they fell out of our ranking criteria, with holding-period returns of -4.6% and +8.4%,...

Logo
113 Views
Share
•09 Jul 2026 11:14•Broker

Krungthai XSpring Zoom Eng. July 9, 2026

(+) Chipmakers rebound, led by Broadcom, after Apple announced a USD30bn chip purchase agreement. (±) Crude oil prices surged more than 5% after...

Logo
111 Views
Share
•19 Jun 2026 07:39•Broker

Krungthai XSpring Zoom Eng. June 18, 2026

The Fed unanimously voted to keep the policy rate unchanged at 3.50–3.75%, in line with expectations, but signaled one rate hike in 2026.

Logo
96 Views
Share
bullish•KCE Electronics
•09 Oct 2026 10:49•Broker

SET Index OUTLOOK

Humanoid Technology stocks are correcting on reports of OpenAI's revenue miss and concerns over AI investment returns. Brent crude remains...

Logo
84 Views
Share
•01 May 2026 08:01•Broker

Krungthai XSpring Zoom Eng. April 30, 2026

The Fed kept its policy rate unchanged at 3.50–3.75%, but divisions within the FOMC have begun to emerge over the wording of the press release.

Logo
108 Views
Share
x